ArticleThe oncologist2019

Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma.

Theodoros Karantanos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.